Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SPRB Spruce Biosciences, Inc.

已收盘 03-03 16:00:00 EST

55.83

+1.63

+3.00%

盘后55.83

+0.000.00%

18:46 EST

最高55.83	最低53.00	成交量1.49万
今开54.12	昨收54.21	日振幅5.22%
总市值5,950万	流通市值4,898万	总股本106.57万
成交额80.51万	换手率1.69%	流通股本87.73万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SPRB","market":"US","secType":"STK","nameCN":"Spruce Biosciences, Inc.","latestPrice":55.83,"timestamp":1772571600000,"preClose":54.205,"halted":0,"volume":14863,"hourTrading":{"tag":"盘后","latestPrice":55.83,"preClose":55.83,"latestTime":"18:46 EST","volume":12,"amount":654.35,"timestamp":1772581561986,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02997878424499585,"floatShares":877301,"shares":1065700,"eps":-82.47875,"marketStatus":"已收盘","change":1.625,"latestTime":"03-03 16:00:00 EST","open":54.12,"high":55.83,"low":53,"amount":805064.442388,"amplitude":0.052209,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-82.47875,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772614800000},"marketStatusCode":5,"adr":0,"listingDate":1602216000000,"exchange":"NASDAQ","adjPreClose":54.205,"postHourTrading":{"tag":"盘后","latestPrice":55.83,"preClose":55.83,"latestTime":"18:46 EST","volume":12,"amount":654.35,"timestamp":1772581561986,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.571065,"impliedVol":0.883,"impliedVolPercentile":0.9908},"requestUrl":"/m/hq/s/SPRB","defaultTab":"news","newsList":[{"id":"2614725490","title":"Spruce Biosciences, Inc.股价上涨11.98% 市值涨269.69万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614725490","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614725490?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:57","pubTimestamp":1771945072,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日22时57分，Spruce Biosciences, Inc.股票出现波动，股价大幅拉升11.98%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602242257529541d5e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602242257529541d5e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","SPRBD","BK4139"],"gpt_icon":0},{"id":"1135613257","title":"Spruce Biosciences股价飙升8.16%，公司推进罕见儿童脑部疾病药物向FDA提交申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1135613257","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135613257?lang=zh_cn&edition=full","pubTime":"2026-02-18 22:35","pubTimestamp":1771425349,"startTime":"0","endTime":"0","summary":"Spruce Biosciences, Inc.股价录得显著上涨，单日涨幅达8.16%。此次股价波动源于公司宣布其针对罕见儿童脑部疾病治疗的药物研发取得关键进展，正式迈向向美国食品药品监督管理局（FDA）提交申请的阶段。\n这一里程碑事件激发了市场对该公司未来商业化前景的积极预期，投资者信心得到提振。该药物的目标适应症为一种罕见的儿童脑部疾病，若最终获得FDA批准，将有望填补该治疗领域的空白。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"1196247101","title":"Spruce Biosciences与美国FDA就治疗B型圣菲利波综合征药物TA-ERT举行B类会议取得积极进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1196247101","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196247101?lang=zh_cn&edition=full","pubTime":"2026-02-18 20:03","pubTimestamp":1771416230,"startTime":"0","endTime":"0","summary":"Spruce Biosciences公司近日宣布，其针对B型圣菲利波综合征（又称MPS IIIB）的候选药物TA-ERT，在与美国食品药品监督管理局（FDA）举行的B类会议上获得了积极反馈。此次会议重点讨论了该药物的临床开发计划，双方就后续试验方案达成重要共识，为推进TA-ERT的研发进程奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2608362407","title":"Spruce Biosciences, Inc.盘中异动 股价大涨5.14%报82.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608362407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608362407?lang=zh_cn&edition=full","pubTime":"2026-02-04 04:47","pubTimestamp":1770151670,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日04时47分，Spruce Biosciences, Inc.股票出现波动，股价大幅拉升5.14%。截至发稿，该股报82.00美元/股，成交量2.6059万股，换手率2.43%，振幅3.83%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204044750a478c38e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204044750a478c38e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB","SPRBD"],"gpt_icon":0},{"id":"1175232475","title":"重新发布-Spruce Biosciences, Inc. : H.c. Wainwright 宣布覆盖，给予买入评级和目标价220美元（澄清为宣布覆盖）","url":"https://stock-news.laohu8.com/highlight/detail?id=1175232475","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175232475?lang=zh_cn&edition=full","pubTime":"2025-12-22 19:25","pubTimestamp":1766402745,"startTime":"0","endTime":"0","summary":"重新发布-Spruce Biosciences, Inc. : H.c. Wainwright 宣布覆盖，给予买入评级和目标价220美元（澄清为宣布覆盖）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"1137422413","title":"Spruce Biosciences, Inc.：H.c. Wainwright启动覆盖并给予买入评级，目标价为220美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137422413","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137422413?lang=zh_cn&edition=full","pubTime":"2025-12-22 19:10","pubTimestamp":1766401812,"startTime":"0","endTime":"0","summary":"Spruce Biosciences, Inc.：H.c. Wainwright启动覆盖并给予买入评级，目标价为220美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"1153345003","title":"Spruce Biosciences任命资深制药商业领袖Keli Walbert为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1153345003","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153345003?lang=zh_cn&edition=full","pubTime":"2025-12-15 21:01","pubTimestamp":1765803688,"startTime":"0","endTime":"0","summary":"Spruce Biosciences任命资深制药商业领袖Keli Walbert为董事会成员","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"1189875027","title":"Spruce Biosciences股价在盘前上涨2.6%，因Leerink Partners将评级从“市场表现”上调至“跑赢大盘”","url":"https://stock-news.laohu8.com/highlight/detail?id=1189875027","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189875027?lang=zh_cn&edition=full","pubTime":"2025-12-03 19:26","pubTimestamp":1764761177,"startTime":"0","endTime":"0","summary":"Spruce Biosciences股价在盘前上涨2.6%，此前Leerink Partners将其评级从“市场表现”上调至“跑赢大盘”。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2580274824","title":"Spruce Biosciences, Inc.盘中异动 早盘快速下挫5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580274824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580274824?lang=zh_cn&edition=full","pubTime":"2025-11-03 23:08","pubTimestamp":1762182529,"startTime":"0","endTime":"0","summary":"北京时间2025年11月03日23时08分，Spruce Biosciences, Inc.股票出现波动，股价大幅下跌5.54%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.94%。其相关个股中，Terns Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Phio Pharmaceuticals Corp.、Tharimmune, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为2006.68%、508.29%、358.95%，振幅较大的相关个股有Tharimmune, Inc.、Surrozen Inc C/Wts 01/08/2031 、Ethzilla Corporation C/Wts 06/11/2025，振幅分别为126.64%、74.07%、63.35%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110323085094ec6474&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110323085094ec6474&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRBD","SPRB","BK4139"],"gpt_icon":0},{"id":"1151924648","title":"Spruce Biosciences盘初暴涨超71%，两天飙升超2400%！","url":"https://stock-news.laohu8.com/highlight/detail?id=1151924648","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151924648?lang=zh_cn&edition=full","pubTime":"2025-10-07 21:50","pubTimestamp":1759845033,"startTime":"0","endTime":"0","summary":"新疗法获得FDA突破性疗法认定。","market":"us","thumbnail":"https://static.tigerbbs.com/834a7c860b61f7246c35ab4c388d5f14","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/834a7c860b61f7246c35ab4c388d5f14"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a7561b70b4a3f3fb25e92e652f8f7604","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRB"],"gpt_icon":0},{"id":"2573963667","title":"Spruce Biosciences股价再度上涨55.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573963667","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573963667?lang=zh_cn&edition=full","pubTime":"2025-10-07 21:44","pubTimestamp":1759844665,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a7561b70b4a3f3fb25e92e652f8f7604","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2573130966","title":"Omniab, Inc.盘中异动 临近午盘股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573130966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573130966?lang=zh_cn&edition=full","pubTime":"2025-10-06 23:45","pubTimestamp":1759765548,"startTime":"0","endTime":"0","summary":"北京时间2025年10月06日23时45分，Omniab, Inc.股票出现波动，股价大幅上涨5.21%。截至发稿，该股报1.72美元/股，成交量17.9374万股，换手率0.12%，振幅6.13%。Omniab, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Spruce Biosciences, Inc.、Leap Therapeutics, Inc.、Moolec Science Sa C/Wts 涨幅较大，Spruce Biosciences, Inc.、Palisade Bio, Inc.、Leap Therapeutics, Inc.较为活跃，换手率分别为3609.86%、391.22%、102.32%，振幅较大的相关个股有Spruce Biosciences, Inc.、Leap Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为195.80%、60.06%、50.25%。Omniab, Inc.公司简介：OmniAb Inc 提供治疗性抗体发现技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510062345489721a24e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510062345489721a24e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4139","SPRB","OABI"],"gpt_icon":0},{"id":"2573987931","title":"Xencor, Inc.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573987931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573987931?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:49","pubTimestamp":1759758583,"startTime":"0","endTime":"0","summary":"北京时间2025年10月06日21时49分，Xencor, Inc.股票出现波动，股价大幅上涨5.06%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Spruce Biosciences, Inc.、Leap Therapeutics, Inc.、Moolec Science Sa C/Wts 涨幅较大，Spruce Biosciences, Inc.、Palisade Bio, Inc.、Leap Therapeutics, Inc.较为活跃，换手率分别为2630.46%、118.26%、45.05%，振幅较大的相关个股有Spruce Biosciences, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Leap Therapeutics, Inc.，振幅分别为164.63%、28.44%、27.33%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100621494394bcde22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100621494394bcde22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139","XNCR"],"gpt_icon":0},{"id":"2573029601","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 早盘股价大涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573029601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573029601?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:39","pubTimestamp":1759757990,"startTime":"0","endTime":"0","summary":"北京时间2025年10月06日21时39分，Sonnet Biotherapeutics Holdings, Inc.股票出现异动，股价大幅拉升5.51%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Spruce Biosciences, Inc.、Moolec Science Sa C/Wts 、Leap Therapeutics, Inc.涨幅较大，Spruce Biosciences, Inc.、Palisade Bio, Inc.、Leap Therapeutics, Inc.较为活跃，换手率分别为1839.69%、73.42%、22.00%，振幅较大的相关个股有Spruce Biosciences, Inc.、Leap Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为72.00%、23.19%、11.48%。Sonnet Biotherapeutics Holdings, Inc.公司简介：Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006213950a4552c61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006213950a4552c61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SONN","SPRB","BK4139"],"gpt_icon":0},{"id":"2573867605","title":"Palisade Bio, Inc.股价上涨21.25% 市值涨384.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2573867605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573867605?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:31","pubTimestamp":1759757470,"startTime":"0","endTime":"0","summary":"北京时间2025年10月06日21时31分，Palisade Bio, Inc.股票出现异动，股价大幅拉升21.25%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Spruce Biosciences, Inc.、Leap Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Spruce Biosciences, Inc.、Palisade Bio, Inc.、Leap Therapeutics, Inc.较为活跃，换手率分别为1809.08%、62.08%、19.47%，振幅较大的相关个股有Spruce Biosciences, Inc.、Leap Therapeutics, Inc.、Osr Holdings, Inc.，振幅分别为53.97%、9.52%、8.85%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006213110a45529fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006213110a45529fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB","BK4007","PALI"],"gpt_icon":0},{"id":"1117912765","title":"Spruce Biosciences盘前飙升超300%，公司获得突破性疗法认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1117912765","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117912765?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:11","pubTimestamp":1759756295,"startTime":"0","endTime":"0","summary":"获得FDA突破性疗法认定。","market":"us","thumbnail":"https://static.tigerbbs.com/834a7c860b61f7246c35ab4c388d5f14","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/834a7c860b61f7246c35ab4c388d5f14"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"98aa5a071838dbc09973453e152cc1ef","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Spruce Biosciences新疗法获得FDA的突破性疗法认定","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRB"],"gpt_icon":1},{"id":"2516632349","title":"Spruce Biosciences, Inc.盘中异动 大幅下挫9.23%报0.353美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516632349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516632349?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:32","pubTimestamp":1741012321,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时32分，Spruce Biosciences, Inc.股票出现异动，股价大幅跳水9.23%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.26%、26.91%、22.55%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Cibus, Inc.，振幅分别为21.22%、19.25%、9.55%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223201abe63345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223201abe63345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2514378974","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大涨6.13%报0.405美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514378974?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:33","pubTimestamp":1740753182,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时33分，Spruce Biosciences, Inc.股票出现波动，股价急速上涨6.13%。截至发稿，该股报0.405美元/股，成交量1.7316万股，换手率0.04%，振幅6.62%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223302abe0eaf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223302abe0eaf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2513773326","title":"Spruce Biosciences, Inc.盘中异动 股价大跌5.12%报0.399美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513773326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513773326?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:08","pubTimestamp":1740409726,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时08分，Spruce Biosciences, Inc.股票出现异动，股价快速下挫5.12%。截至发稿，该股报0.399美元/股，成交量9.7834万股，换手率0.24%，振幅3.95%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230847abdb16f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230847abdb16f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2513961772","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大跌5.67%报0.401美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513961772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513961772?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148295,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Spruce Biosciences, Inc.股票出现异动，股价大幅下挫5.67%。截至发稿，该股报0.401美元/股，成交量1.7247万股，换手率0.04%，振幅0.00%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223136a24eb02f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223136a24eb02f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sprucebiosciences.com","stockEarnings":[{"period":"1week","weight":0.0117},{"period":"1month","weight":-0.301},{"period":"3month","weight":-0.3923},{"period":"6month","weight":400.5185},{"period":"1year","weight":138.3445},{"period":"ytd","weight":-0.3777}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0081},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.0662},{"period":"1year","weight":0.1552},{"period":"ytd","weight":0.0065}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Spruce Biosciences, Inc.最初于2014年11月在特拉华州成立为一家有限责任公司。该公司是一家处于后期阶段的生物制药公司，专注于开发和商业化治疗罕见的内分泌疾病的新疗法，这些疾病的医疗需求尚未得到满足。该公司正在初步开发全资候选产品tildacerfont，作为潜在的第一个非甾体疗法，为患有典型先天性肾上腺增生症的患者提供显著改善的疾病控制和减少类固醇负担。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.190445},{"month":2,"riseRate":0.5,"avgChangeRate":-0.036118},{"month":3,"riseRate":0,"avgChangeRate":-0.242859},{"month":4,"riseRate":0,"avgChangeRate":-0.208561},{"month":5,"riseRate":0.4,"avgChangeRate":-0.03765},{"month":6,"riseRate":0.4,"avgChangeRate":-0.079875},{"month":7,"riseRate":0.6,"avgChangeRate":0.089441},{"month":8,"riseRate":0.4,"avgChangeRate":0.028537},{"month":9,"riseRate":0.4,"avgChangeRate":-0.136102},{"month":10,"riseRate":0.4,"avgChangeRate":2.105377},{"month":11,"riseRate":0.5,"avgChangeRate":0.001192},{"month":12,"riseRate":0.333333,"avgChangeRate":0.217863}],"exchange":"NASDAQ","name":"Spruce Biosciences, Inc.","nameEN":"Spruce Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Spruce Biosciences, Inc.(SPRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Spruce Biosciences, Inc.,SPRB,Spruce Biosciences, Inc.股票,Spruce Biosciences, Inc.股票老虎,Spruce Biosciences, Inc.股票老虎国际,Spruce Biosciences, Inc.行情,Spruce Biosciences, Inc.股票行情,Spruce Biosciences, Inc.股价,Spruce Biosciences, Inc.股市,Spruce Biosciences, Inc.股票价格,Spruce Biosciences, Inc.股票交易,Spruce Biosciences, Inc.股票购买,Spruce Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Spruce Biosciences, Inc.(SPRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}